Laurion Capital Management »

Iteos Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $549k 50k 10.95

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Broadcom Call Option (AVGO)
Ishares Tr Msci Eafe Etf (EFA)
Tesla Motors Call Option (TSLA)
Boeing Company (BA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Home Depot (HD)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)

View all positions for Laurion Capital Management

Top funds holding Iteos Therapeutics

RA Capital Management
BlackRock
MPM Asset Management
EcoR1 Capital
Boxer Capital
MPM Oncology Impact Management
Morgan Stanley
Vanguard Group
Citadel Advisors
Braidwell
Millennium Management
Dimensional Fund Advisors
Deerfield Management Company
Goldman Sachs Group
683 Capital Management

View all funds holding Iteos Therapeutics